Abstract: A pipe welding stabilizer comprising a vise grip assembly, an adjustment assembly, and a pipe assembly. The vise grip assembly includes two vise grips mounted to either side of an adjustment assembly. The two vise grips include jaws with ridges that can be attached to a pipe surface. The vise grips help hold the pipe in place while it is being soldered to ensure it does not slip or fall before it is welded. The adjustment assembly includes pins that can be pushed in to adjust the width and reach of the grip of the two vise grips.

Abstract: A method of communicating a patient care message is disclosed. The method comprises inputting patient information into the patient care message; inputting an urgency indicator into the patient care message; inputting health condition information into the patient care message; transmitting the patient care message electronically, wherein the patient care message comprises the patient information, the urgency indicator, and the health condition information.

Abstract: A method of communicating a patient care message is disclosed. The method comprises inputting patient information into the patient care message; inputting an urgency indicator into the patient care message; inputting health condition information into the patient care message; transmitting the patient care message electronically, wherein the patient care message comprises the patient information, the urgency indicator, and the health condition information.

Abstract: The invention concerns a method of treatment or prophylaxis of depression by administering a phenylethanolaminocyclohexylphenyl compound of a general formula (I) in which R1 represents hydrogen or halogen; R2 represents hydrogen, hydroxy, lower alkoxy, lower alkoxy substituted with one or two lower alkoxycarbonyl or carboxy groups, lower alkoxy substituted with lower alkylaminocarbonyl which may be substituted with lower alkoxy, lower alkoxy substituted with cyclic aminocarbonyl of 4 to 6 carbon atoms, lower alkoxycarbonyl or carboxy; R3 represents hydrogen, hydroxy, lower alkoxy or lower alkoxy substituted with one or two lower alkoxycarbonyl or carboxy groups; R2 and R3 may be bonded to each other to form methylenedioxy substituted with carboxy or lower alkoxycarbonyl; and m and n are 0 or 1, and their pharmacologically acceptable metabolites or salts, which have selective stimulating activity and binding affinity for ?3 adrenergic receptors.

Abstract: A pharmaceutical composition comprising a compound of formula (1) in polymorphic crystalline Form A: together with a pharmaceutically acceptable carrier or excipient, wherein the compound of formula (1) is present in polymorphic Form A (see, e.g., FIG. 6) substantially free of other polymorphic forms.

Abstract: Process for making a pharmaceutical composition, comprising: a compound of formula (1) in crystalline form: together with a pharmaceutically acceptable carrier or excipient, wherein the compound of formula (1) is present in polymorphic crystal form A substantially free of other polymorphs, and methods for making this polymorph.

Abstract: A method of treating interstitial cystitis, irritable bowel syndrome, ulcerative colitis, and other inflammatory conditions, comprising: administering to a patient in need thereof an effective amount of a compound selected from compound 1, its metabolite 2 and pharmaceutically acceptable salts or prodrugs thereof: